Fundz

Cypris Therapeutics secures over $500k in pre-seed funding led by Ichor Life Sciences

PRIVATEJun 24, 2024

Amount Raised

$500,000

Round Type

Pre-Seed

City Of SyracuseBiotechnologyHealth CareTherapeutics

Investors

Ichor Life Sciences

Description

Cypris Therapeutics, a drug discovery company, has secured over $500k in pre-seed funding from Ichor Life Sciences. The company's proprietary technology enables the synthesis and iteration of complex small molecule moieties to develop novel chemistries for treatment of therapeutically resistant diseases, including brain and pancreatic cancers.

Quick answer

Cypris Therapeutics raised $500,000 in a Pre-Seed round, dated June 24, 2024. Investors: Ichor Life Sciences. Cypris Therapeutics is based in City Of Syracuse, New York, United States.

How much did Cypris Therapeutics raise?
Cypris Therapeutics raised $500,000 in a Pre-Seed round on June 24, 2024.
Who invested in Cypris Therapeutics?
Ichor Life Sciences is named as investors in this round.
What does Cypris Therapeutics do?
Cypris Therapeutics is a drug discovery company focused on developing novel chemistries for the treatment of therapeutically resistant diseases, particularly brain and pancreatic cancers.
Where is Cypris Therapeutics based and how big is it?
Cypris Therapeutics is based in City Of Syracuse, New York, United States.
Who are the decision-makers at Cypris Therapeutics?
Fundz holds 1 contact at Cypris Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Cypris Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • IDRx raised $120M (Series B) on August 7, 2024.
  • NeuroTherapia raised $12M (Series B) on August 6, 2024.
  • bioAffinity Technologies raised $450K on August 5, 2024.
  • Lapix Therapeutics raised $2.2M on August 2, 2024.
  • bioAffinity Technologies raised $1.3M on August 2, 2024.
  • Healx raised $47M (Series C) on August 1, 2024.

Who to call at Cypris Therapeutics, and when

A new round usually means Cypris Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Cypris Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Cypris Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Cypris Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Cypris Therapeutics

Location

City Of Syracuse, New York, United States

About

Cypris Therapeutics is a drug discovery company focused on developing novel chemistries for the treatment of therapeutically resistant diseases, particularly brain and pancreatic cancers. The company's proprietary technology enables the synthesis and iteration of complex small molecule moieties inspired by natural molecules with demonstrated therapeutic properties. Cypris Therapeutics aims to significantly improve the standard of care for patients that do not respond to existing treatments.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Cypris Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Cypris Therapeutics's next move

See what Strategic adds

Cypris Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.